Janelle Taylor

1PUBLICATIONS
12CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 18, 2023
HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast Cancer.

Devra Olson, Janelle Taylor, Kelsi Willis

Pageof 1

Frequent Collaborators

1 joint publications

Devra Olson

1 joint publications

Kelsi Willis

1 joint publications

Kelly Hensley

1 joint publications

Sean Allred